tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PRTA Stock Latest News

Prothena price target raised to $110 from $94 at Piper Sandler
The FlyProthena price target raised to $110 from $94 at Piper Sandler
29d ago
PRTA
Prothena Reports 2024 Financial Results and 2025 Outlook
PremiumCompany Announcements
Prothena Reports 2024 Financial Results and 2025 Outlook
1M ago
PRTA
Prothena’s Balanced Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Prothena’s Balanced Earnings Call Highlights Growth and Challenges
1M ago
PRTA
Prothena price target lowered to $20 from $24 at RBC Capital
PremiumThe Fly
Prothena price target lowered to $20 from $24 at RBC Capital
1M ago
PRTA
Promising Potential of Birtamimab in Transforming AL Amyloidosis Treatment: Analyst Recommends Buy
PremiumRatings
Promising Potential of Birtamimab in Transforming AL Amyloidosis Treatment: Analyst Recommends Buy
1M ago
PRTA
PRTA Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsPRTA Upcoming Earnings Report: What to Expect?
1M ago
PRTA
Prothena price target raised to $62 from $58 at Oppenheimer
Premium
The Fly
Prothena price target raised to $62 from $58 at Oppenheimer
2M ago
PRTA
Prothena initiated with a Buy at Chardan
Premium
The Fly
Prothena initiated with a Buy at Chardan
3M ago
PRTA
Prothena price target lowered to $48 from $84 at H.C. Wainwright
PremiumThe Fly
Prothena price target lowered to $48 from $84 at H.C. Wainwright
3M ago
PRTA
RBC sees justification for Prothena rebound after study miss
PremiumThe Fly
RBC sees justification for Prothena rebound after study miss
3M ago
PRTA
Prothena price target lowered to $22 from $26 at BofA
PremiumThe Fly
Prothena price target lowered to $22 from $26 at BofA
3M ago
PRTA
Prothena price target lowered to $58 from $62 at Oppenheimer
PremiumThe Fly
Prothena price target lowered to $58 from $62 at Oppenheimer
3M ago
PRTA
Capricor, Gilead, Kymera, Praxis among Oppenheimer’s top biotech picks for 2025
PremiumThe FlyCapricor, Gilead, Kymera, Praxis among Oppenheimer’s top biotech picks for 2025
3M ago
CAPR
GILD
Prothena partner Roche PADOVA study misses primary endpoint
Premium
The Fly
Prothena partner Roche PADOVA study misses primary endpoint
3M ago
PRTA
Prothena Corporation Reports Q3 2024 Financial Results
Premium
Company Announcements
Prothena Corporation Reports Q3 2024 Financial Results
4M ago
PRTA
Prothena reports Q3 EPS ($1.10), consensus ($1.18)
PremiumThe Fly
Prothena reports Q3 EPS ($1.10), consensus ($1.18)
4M ago
PRTA
PRTA Earnings this Week: How Will it Perform?
PremiumPre-Earnings
PRTA Earnings this Week: How Will it Perform?
5M ago
PRTA
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
KZR
BGNE
Prothena price target lowered to $31 from $33 at BofA
PremiumThe Fly
Prothena price target lowered to $31 from $33 at BofA
6M ago
PRTA
Prothena selloff ‘misplaced,’ brings buying opportunity, says H.C. Wainwright
PremiumThe FlyProthena selloff ‘misplaced,’ brings buying opportunity, says H.C. Wainwright
6M ago
PRTA
Prothena’s downside move may be excessive, says RBC Capital
Premium
The Fly
Prothena’s downside move may be excessive, says RBC Capital
6M ago
PRTA
Oppenheimer says Prothena’s Garren left for ‘amazing opportunity’
Premium
The Fly
Oppenheimer says Prothena’s Garren left for ‘amazing opportunity’
6M ago
PRTA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >